Variant report

Variant	esv3316169
Chromosome Location	chr17:15024418-15025891
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 64 )
Associated
traits (count: 133 )

Variant overlapped rSNPs/rCNVs (count:64 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs566105868	chr17:15024477-15024478	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs576292888	chr17:15024485-15024486	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs139667807	chr17:15024495-15024496	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs373794978	chr17:15024521-15024522	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs145410167	chr17:15024534-15024535	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs567448751	chr17:15024542-15024543	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs536059163	chr17:15024558-15024559	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs541162772	chr17:15024559-15024560	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs182711202	chr17:15024645-15024646	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs145259376	chr17:15024656-15024657	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs564643767	chr17:15024711-15024712	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs571743709	chr17:15024746-15024747	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs540719648	chr17:15024810-15024811	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs75950992	chr17:15024827-15024828	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs530267661	chr17:15024834-15024835	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs543669870	chr17:15024872-15024873	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs553420187	chr17:15024881-15024882	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs187137746	chr17:15024904-15024905	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs191625902	chr17:15024922-15024923	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs552936368	chr17:15024930-15024931	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs62072211	chr17:15024980-15024981	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs183029445	chr17:15024993-15024994	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs550150407	chr17:15025018-15025019	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs570338056	chr17:15025021-15025022	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs187357046	chr17:15025039-15025040	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs548613321	chr17:15025087-15025088	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs111725235	chr17:15025139-15025140	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs527857701	chr17:15025145-15025146	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs398058617	chr17:15025150-15025151	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs568473705	chr17:15025151-15025152	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs536415013	chr17:15025168-15025169	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs193020432	chr17:15025181-15025182	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs114906282	chr17:15025214-15025215	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs74254592	chr17:15025220-15025221	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs185594011	chr17:15025241-15025242	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs577941623	chr17:15025252-15025253	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs190519218	chr17:15025279-15025280	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs534326423	chr17:15025303-15025304	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs375596053	chr17:15025322-15025323	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs574469654	chr17:15025330-15025331	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs192427735	chr17:15025346-15025347	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs563714530	chr17:15025350-15025351	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs371178170	chr17:15025370-15025371	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs372920956	chr17:15025415-15025416	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs546513641	chr17:15025430-15025431	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs543686393	chr17:15025464-15025465	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs528450813	chr17:15025512-15025513	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs149131376	chr17:15025518-15025519	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs562186332	chr17:15025519-15025520	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs557468633	chr17:15025527-15025528	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:133)

Disease	PMID	Source
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	17603634	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	19435819	CNVD
Non-small cell lung cancer	19010865	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16774939	CNVD
Hepatocellular carcinoma	18803288	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Multiple myeloma	16616336	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	21509527	CNVD
Sezary syndrome	18413736	CNVD
Pancreatic cancer	21811587	CNVD
Autism	17322880	CNVD
Hereditary neuropathy with liability to pressure palsy	19521722	CNVD
Schizophrenia	19571808	CNVD
Schizophrenia	19955444	CNVD
Charcot-marie-tooth disease	18787571	CNVD
Breast cancer	20409316	CNVD
Autism	18414403	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Myelofibrosis	22110671	CNVD
Peripheral neuropathy	21193943	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	22958593	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	20844748	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	21858162	CNVD
Ovarian cancer	21720365	CNVD
Bipolar disorder	19114987	CNVD
Schizophrenia	20967226	CNVD
Autism	18522746	CNVD
Epilepsy	21635232	CNVD
Autism	22543975	CNVD
Obesity	20622171	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17142309	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:13 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:15005800-15027000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr17:15021800-15025000	Enhancers	Primary neutrophils fromperipheralblood	blood
3	chr17:15023200-15026400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
4	chr17:15023200-15028600	Enhancers	NHDF-Ad	bronchial
5	chr17:15023400-15025600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
6	chr17:15023400-15028600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
7	chr17:15024000-15025000	Enhancers	Gastric	stomach
8	chr17:15024400-15025600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
9	chr17:15024800-15025600	Enhancers	Pancreas	Pancrea
10	chr17:15025000-15025600	Enhancers	Fetal Heart	heart
11	chr17:15025600-15026000	Weak transcription	Fetal Heart	heart
12	chr17:15025600-15026600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
13	chr17:15025600-15027000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links